DNTH
Dianthus Therapeutics, Inc. · Healthcare
EVP, CFO, CBO Ryan Savitz sold $9.5M of Dianthus Therapeutics, Inc.
Sold$9,492,596
$83.00Price
114,367Shares
−100%Stake
What DNTH did after the filing
- The stock from Thu, Apr 2 open, $82.60
- +4.3%
- S&P 500, same days
- +14.3%
Measured over 30 trading days, to the May 15 close.
Traded Tue, Mar 31. Filed Wed, Apr 1, 5:26 PM ET, after the close. Returns use the Apr 2 open and the May 15 close. Not investment advice.